Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wiebe ST"'
Publikováno v:
Nature and Science of Sleep, Vol 2012, Iss default, Pp 73-80 (2012)
Jamie Cassoff,1,2 Sabrina T Wiebe,1,2 Reut Gruber1,21Attention, Behavior and Sleep Lab, Douglas Mental Health University Institute, Montréal, Quebec, Canada; 2McGill University, Montréal, Quebec, CanadaAbstract: Attention-deficit/hyperactivity diso
Externí odkaz:
https://doaj.org/article/01d5355c41184a30b39a128ca16d288d
Publikováno v:
Nature and Science of Sleep, Vol 2012, Iss default, Pp 63-71 (2012)
Sabrina T Wiebe, Jamie Cassoff, Reut GruberAttention, Behavior and Sleep Laboratory, Douglas Mental Health University Institute, Montréal; McGill University, Montréal, Quebec, CanadaAbstract: Psychological disorders, particularly mood disorders, su
Externí odkaz:
https://doaj.org/article/b45e13c70bfe4c2d9dd314847d38c6f9
Autor:
Adam Doherty, Sylvain Fourmaux, Alberto Astolfo, Ralf Ziesche, Jonathan Wood, Oliver Finlay, Wiebe Stolp, Darren Batey, Ingo Manke, François Légaré, Matthieu Boone, Dan Symes, Zulfikar Najmudin, Marco Endrizzi, Alessandro Olivo, Silvia Cipiccia
Publikováno v:
Communications Physics, Vol 6, Iss 1, Pp 1-8 (2023)
Abstract Laser-plasma accelerators are compact linear accelerators based on the interaction of high-power lasers with plasma to form accelerating structures up to 1000 times smaller than standard radiofrequency cavities, and they come with an embedde
Externí odkaz:
https://doaj.org/article/cf7d52b1c5ea428ea8466f4074afc565
Autor:
Adam Doherty, Sylvain Fourmaux, Alberto Astolfo, Ralf Ziesche, Jonathan Wood, Oliver Finlay, Wiebe Stolp, Darren Batey, Ingo Manke, François Légaré, Matthieu Boone, Dan Symes, Zulfikar Najmudin, Marco Endrizzi, Alessandro Olivo, Silvia Cipiccia
Publikováno v:
Communications Physics, Vol 6, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/abe93afd9399489ca132aa72e3b23cb7
Autor:
Fuertig R; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Binger Str. 173, 55218, Ingelheim am Rhein, Germany., Goettel M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Binger Str. 173, 55218, Ingelheim am Rhein, Germany. markus.goettel@boehringer-ingelheim.com., Herich L; Staburo GmbH, München, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Hoefler J; Staburo GmbH, München, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Wiebe ST; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Binger Str. 173, 55218, Ingelheim am Rhein, Germany., Sharma V; Boehringer Ingelheim International GmbH, Ingelheim-am-Rhein, Germany.
Publikováno v:
CNS drugs [CNS Drugs] 2023 Dec; Vol. 37 (12), pp. 1081-1097. Date of Electronic Publication: 2023 Nov 29.
Autor:
Wiebe ST; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Huennemeyer A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Kadus W; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Goettel M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Jambrecina A; CTC North GmbH & Co KG, University Medical Centre Hamburg Eppendorf, Hamburg, Germany., Schultz A; CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany., Vinisko R; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Schlieker L; Staburo GmbH, München, Germany on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG., Herich L; Staburo GmbH, München, Germany on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG., Mikus G; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jan; Vol. 87 (1), pp. 178-188. Date of Electronic Publication: 2020 Jun 10.
Autor:
Wiebe ST; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Meid AD; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Mikus G; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. gerd.mikus@med.uni-heidelberg.de.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2020 Dec; Vol. 47 (6), pp. 527-542. Date of Electronic Publication: 2020 Aug 08.
Autor:
Wiebe ST; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.; UniversitätsKlinikum Heidelberg-Medizinische Klinik, Abteilung Klinische Pharmakologie and Pharmakoepidemiologie, Heidelberg, Germany., Giessmann T; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Hohl K; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Schmidt-Gerets S; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Hauel E; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Jambrecina A; CTC North GmbH & Co KG, University Medical Centre Hamburg Eppendorf, Hamburg, Germany., Bader K; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Ishiguro N; Kobe Pharma Research Institute, Nippon Boehringer Ingelheim Co. Ltd., Chuo-ku, Kobe, Japan., Taub ME; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Sharma A; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Ebner T; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany., Mikus G; UniversitätsKlinikum Heidelberg-Medizinische Klinik, Abteilung Klinische Pharmakologie and Pharmakoepidemiologie, Heidelberg, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Müller F; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Stopfer P; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany. Peter.Stopfer@boehringer-ingelheim.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2020 Dec; Vol. 59 (12), pp. 1627-1639.
Autor:
Gruber R; McGill University, Montreal, QC, Canada. reut.gruber@douglas.mcgill.ca, Fontil L, Bergmame L, Wiebe ST, Amsel R, Frenette S, Carrier J
Publikováno v:
BMC psychiatry [BMC Psychiatry] 2012 Nov 28; Vol. 12, pp. 212. Date of Electronic Publication: 2012 Nov 28.
Autor:
Gruber R; Department of Psychiatry, Douglas Mental Health University Institute, Montreal, Quebec, Canada. reut.gruber@douglas.mcgill.ca, Wiebe ST, Wells SA, Cassoff J, Monson E
Publikováno v:
Adolescent medicine: state of the art reviews [Adolesc Med State Art Rev] 2010 Dec; Vol. 21 (3), pp. 522-41, x.